Demonstrating the burden of hypoglycemia on patients' quality of life in diabetes clinical trials: Measurement considerations for hypoglycemia

Value in Health

Volumn 15, Issue 8, 2012, Pages 1036-1041

  Gilet, Hélène ^a   Gruenberger, Jean Bernard ^b   Bader, Giovanni ^b   Viala Danten, Muriel ^a  

^a Mapi Consultancy   (France)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

clinical trial; diabetes; health related quality of life; hypoglycemia; measurement

Indexed keywords

GLIMEPIRIDE; GLUCOSE; METFORMIN; VILDAGLIPTIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DOUBLE BLIND PROCEDURE; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HUMAN; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SHORT FORM 36;

ADULT; AGED; BLOOD GLUCOSE; CLINICAL TRIALS, PHASE III AS TOPIC; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; YOUNG ADULT;

EID: 84871235723     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2012.06.002     Document Type: Article

References (41)

1. Z. Liu, C. Fu, and W. Wang Prevalence of chronic complications of type 2 diabetes mellitus in outpatients - a cross-sectional hospital based survey in urban China Health Qual Life Outcomes 8 2010 62
2. M.L. Pedersen, J.L. Jacobsen, and A.R. Lynge Micro- and macrovascular complications among Greenlanders and Danes with type 2 diabetes mellitus in Nuuk, Greenland Int J Circumpolar Health 69 2010 195 207
3. N. Reynoso-Noveron, R. Mehta, and P. Meda-Valdes Estimated incidence of cardiovascular complications related to type 2 diabetes in Mexico using the UKPDS outcome model and a population-based survey Cardiovasc Diabetol 10 2011 1
4. M. Stolar Glycemic control and complications in type 2 diabetes mellitus Am J Med 123 3, Suppl. 2010 S3 S11
5. O.P. Hamnvik, and G.T. McMahon Balancing risk and benefit with oral hypoglycemic drugs Mt Sinai J Med 76 2009 234 243
6. C.H. Wysham New perspectives in type 2 diabetes, cardiovascular risk, and treatment goals Postgrad Med 122 2010 52 60
7. A.S. Gangji, T. Cukierman, and H.C. Gerstein A systematic review and meta-analysis of hypoglycemia and cardiovascular events: a comparison of glyburide with other secretagogues and with insulin Diabetes Care 30 2007 389 394 (Pubitemid 46198354)
8. J. Tayek SUR receptor activity vs. incidence of hypoglycaemia and cardiovascular mortality with sulphonylurea therapy for diabetics Diabetes Obes Metab 10 2008 1128 1129
9. S.S. Johnston, C. Conner, and M. Aagren Evidence linking hypoglycemic events to an increased risk of acute cardiovascular events in patients with type 2 diabetes Diabetes Care 34 2011 1164 1170
10. R.A. Whitmer, A.J. Karter, and K. Yaffe Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus JAMA 301 2009 1565 1572
11. J.E. Foley, and J. Jordan Weight neutrality with the DPP-4 inhibitor, vildagliptin: mechanistic basis and clinical experience Vasc Health Risk Manag 6 2010 541 548
12. EMA - Committee for Medicinal Products for Human Use Guideline on Clinical Investigation of Medicinal Products in the Treatment of Diabetes Mellitus 2010 EMA London
13. U.S. Department of Health and Human Services, FDA, Center for Drug Evaluation and Research Guidance for Industry-Diabetes Mellitus: Developing Drugs and Therapeutic Biologics for Treatment and Prevention 2008 FDA Rockville, MD
14. P.E. Cryer, S.N. Davis, and H. Shamoon Hypoglycemia in diabetes Diabetes Care 26 2003 1902 1912 (Pubitemid 36929141)
15. R. Kazlauskaite, S. Soni, and A.T. Evans Accuracy of self-monitored blood glucose in type 2 diabetes Diabetes Technol Ther 11 2009 385 392
16. R.A. Vigersky An overview of management issues in adult patients with type 2 diabetes mellitus J Diabetes Sci Technol 5 2011 245 250
17. C. Fidler, C.T. Elmelund, and S. Gillard Hypoglycemia: an overview of fear of hypoglycemia, quality-of-life, and impact on costs J Med Econ 14 2011 646 655
18. L.C. Hay, E.G. Wilmshurst, and G. Fulcher Unrecognized hypo- and hyperglycemia in well-controlled patients with type 2 diabetes mellitus: the results of continuous glucose monitoring Diabetes Technol Ther 5 2003 19 26 (Pubitemid 36506086)
19. F. Alvarez Guisasola, P.S. Tofe, and G. Krishnarajah Hypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) study Diabetes Obes Metab 10 Suppl. 1 2008 25 32
20. E. Marrett, T. Stargardt, and P. Mavros Patient-reported outcomes in a survey of patients treated with oral antihyperglycaemic medications: associations with hypoglycaemia and weight gain Diabetes Obes Metab 11 2009 1138 1144
21. UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 1998 837 853
22. S.E. Kahn, S.M. Haffner, and M.A. Heise Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy N Engl J Med 355 2006 2427 2443 (Pubitemid 44903747)
23. J.A. Dormandy, B. Charbonnel, and D.J. Eckland Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective PioglitAzone Clinical Trial In MacroVascular Events): a randomised controlled trial Lancet 366 2005 1279 1289 (Pubitemid 41416583)
24. S.A. Amiel, T. Dixon, and R. Mann Hypoglycaemia in type 2 diabetes Diabet Med 25 2008 245 254 (Pubitemid 351322690)
25. F. Hill-Briggs, T.L. Gary, and K. Baptiste-Roberts Thirty-six-item short-form outcomes following a randomized controlled trial in type 2 diabetes Diabetes Care 28 2005 443 444 (Pubitemid 40170960)
26. J.K. Kaukua, T.A. Pekkarinen, and A.M. Rissanen Health-related quality of life in a randomised placebo-controlled trial of sibutramine in obese patients with type II diabetes Int J Obes Relat Metab Disord 28 2004 600 605 (Pubitemid 38491152)
27. M. van den Donk, K.J. Gorter, G.E. Rutten The ADDITION-Netherlands Study No negative effects of a multi-factorial, intensified treatment on self-reported health status, treatment satisfaction, and diabetes-related distress in screen-detected type 2 diabetes patients Qual Life Res 19 2010 509 513
28. J.P. Walsh, L. Shiels, and E.M. Lim Combined thyroxine/liothyronine treatment does not improve well-being, quality of life, or cognitive function compared to thyroxine alone: a randomized controlled trial in patients with primary hypothyroidism J Clin Endocrinol Metab 88 2003 4543 4550 (Pubitemid 37357490)
29. B. Pettersson, U. Rosenqvist, and A. Deleskog Self-reported experience of hypoglycemia among adults with type 2 diabetes mellitus (Exhype) Diabetes Res Clin Pract 92 2011 19 25
30. S.A. Williams, M.F. Pollack, and M. DiBonaventura Effects of hypoglycemia on health-related quality of life, treatment satisfaction and healthcare resource utilization in patients with type 2 diabetes mellitus Diabetes Res Clin Pract 91 2011 363 370
31. F. Alvarez Guisasola, D.D. Yin, and G. Nocea Association of hypoglycemic symptoms with patients' rating of their health-related quality of life state: a cross sectional study Health Qual Life Outcomes 8 2010 86
32. R.E. Davis, M. Morrissey, and J.R. Peters Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes Curr Med Res Opin 21 2005 1477 1483 (Pubitemid 41368581)
33. G. Jermendy, D. Erdesz, and L. Nagy Outcomes of adding second hypoglycemic drug after metformin monotherapy failure among type 2 diabetes in Hungary Health Qual Life Outcomes 6 2008 88
34. D.R. Matthews, S. Dejager, and B. Ahren Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year study Diabetes Obes Metab 12 2010 780 789
35. C.A. McHorney, J.E. Ware Jr, and J.F. Lu The MOS 36-Item Short-Form Health Survey (SF-36), III: tests of data quality, scaling assumptions, and reliability across diverse patient groups Med Care 32 1 1994 40 66
36. C.A. McHorney, S.M. Haley, and J.E. Ware Jr Evaluation of the MOS SF-36 Physical Functioning Scale (PF-10), II: comparison of relative precision using Likert and Rasch scoring methods J Clin Epidemiol 50 1997 451 461 (Pubitemid 27223275)
37. J.E. Ware Jr, and C.D. Sherbourne The MOS 36-Item Short-Form Health Survey (SF-36), I: conceptual framework and item selection Med Care 30 1992 473 483
38. C. Bradley, and K.S. Lewis Measures of psychological well-being and treatment satisfaction developed from the responses of people with tablet-treated diabetes Diabet Med 7 1990 445 451 (Pubitemid 20183935)
39. C. Bradley The Diabetes Treatment Satisfaction Questionnaire: DTSQ Handbook of Psychology and Diabetes: A Guide to Psychological Measurement in Diabetes Research and Practice 1994 Harwood Academic Publishers Chur, Switzerland
40. C.D. Miller, L.S. Phillips, and D.C. Ziemer Hypoglycemia in patients with type 2 diabetes mellitus Arch Intern Med 161 2001 1653 1659 (Pubitemid 32681147)
41. D. Wild, M.R. von, and E. Brohan A critical review of the literature on fear of hypoglycemia in diabetes: implications for diabetes management and patient education Patient Educ Couns 68 2007 10 15 (Pubitemid 47126791)